Navigation Links
Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
Date:4/28/2008

- IVIS Imaging System Provides Real-Time Insight on Viability of Infectious

Disease Treatment Options -

HOPKINTON, Mass., April 28 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that the Texas A&M Health Science Center Research Foundation (HSCRF) is using the IVIS Spectrum imaging system to speed the development of more effective therapeutic treatments for tuberculosis. Research efforts and the purchase of the IVIS system are funded through a grant to the Texas A&M Health Science Center from the Bill & Melinda Gates Foundation.

Tuberculosis currently affects nearly one-third of the world's population and remains a global threat due to severe and drug-resistant strains. According to the World Health Organization, tuberculosis is one of the most serious infectious diseases in the world. Caliper is dedicated to assisting the global fight against infectious diseases and aiding the discovery of life-saving treatments.

Researchers at the Texas A&M Health Science Center College of Medicine and a consortium of leading tuberculosis researchers at Washington University and Stanford University School of Medicine are actively studying tuberculosis infections in live animals using in vivo imaging technology. Caliper's IVIS Spectrum was specifically chosen for its highly sensitive luminescence detection and ability to successfully image, track and quantify tuberculosis infections using fluorescence. The IVIS system enables researchers to visualize the progression of the disease and impact of therapeutic candidates in real time. This rapid evaluation of in vivo efficacy allows researchers to quickly adapt efforts and progress towards effective treatments for the disease.

"We are quite optimistic that this research collaboration will uncover new and promising discoveries in the fight against tuberculosis," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Caliper's imaging technology has proven to be integral in other discovery efforts for finding new ways and treatments to combat infectious disease. This is a great opportunity to exploit Caliper's imaging technology to make a major impact in this world."

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Caliper and IVIS are registered trademarks, and Spectrum is a trademark, of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ACME Markets, Delaware County ... Councilman Dave White announced today the availability ... pharmacies across Delaware County . According ... has saved 26,463 lives nationwide over the past 20 years. Since ... were authorized to administer naloxone to overdose victims, 244 lives ...
(Date:5/3/2016)... May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating ... video of two patients who tell their personal story and encourage those at risk to ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... 2016 Intec Pharma Ltd. (NASDAQ: ... company, today announced the appointment of Pnina Strauss-Levy ... "Ms. Strauss-Levy has 15 years of experience in ... outstanding track record, having supported the advancement of several ... in the United States and ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... ... operators of commercial real estate proudly announced that its service-based charitable program, Olshan ... Team members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition in 2016 with ...
(Date:5/4/2016)... ... 04, 2016 , ... A new collaboration will give more researchers access to ... (DCRI) and analytics leader SAS will provide researchers worldwide with data management and analytics ... Health System. , The DCRI and SAS share the goal of greater transparency ...
(Date:5/4/2016)... ... ... May kicked off with Melanoma Monday , a multi-agency effort to raise ... encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, and Plano, ... in the future. , The dermatology-specific awareness month ends with “Don’t Fry Day,” established ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... of foundational nutrients that supports cellular and metabolic health. This synergistic combination of ... mg free-form curcumin, along with 150 mg of reduced glutathione and 200 mg ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... and the pharmacy industry, today announced that it was chosen as the Pharmaceutical ... (APPA) Industry Awards . The awards acknowledge the hard work and dedication of ...
Breaking Medicine News(10 mins):